This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Etern Biopharma (Shanghai) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ye Zhao and a Crystalline Form of an SHP2 Inhibitor.
Introduction
Ye Zhao is an inventor associated with Suzhou, China, and Etern Biopharma (Shanghai) Co., Ltd. The supplied information identifies her as a woman and credits her with 1 patent.
Latest Patents
The patent, “Crystalline Form of SHP2 Inhibitor, and Composition Thereof, Preparation Method Therefor, and Use Thereof,” concerns a novel crystalline form of compound 1, including a hydrate or solvate, and a pharmaceutical composition containing that form. The application also describes methods for preparing the crystalline form and its potential use. The compound is identified by the chemical name (S)-1'-(8-((2-amino-3-chloropyridin-4-yl)thio)imidazo[1,2-c]pyrimidin-5-yl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,4′-piperidine]-5-amine.
Career Highlights
The available information links Zhao’s patent work to pharmaceutical research and development at Etern Biopharma (Shanghai) Co., Ltd. Her listed invention focuses on the crystalline form, preparation, composition, and use of an SHP2 inhibitor.
Collaborations
Qiangang Zheng and Hao Zhuge are identified as Zhao’s coworkers. The supplied information does not specify their roles in the patent or the extent of their collaboration.
Conclusion
Ye Zhao’s listed patent addresses a crystalline form of an SHP2 inhibitor and related pharmaceutical compositions, preparation methods, and uses, reflecting her connection to pharmaceutical innovation at Etern Biopharma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile